Patent applications published 9 March 2011
Selected patent applications from the weekly European Patents Bulletin
- Angiotensin II receptor antagonists
Merck Sharp & Dohme; Nocix 2291076*
- Process for the preparation of rho-kinase inhibitor compounds
Inspire Pharmaceuticals 2291077*
- Oxazolbenzimidazole derivatives
Merck Sharp & Dohme 2291078*
- Formulations for cathepsin K inhibitors
Merck Sharp & Dohme 2291079*
- Novel modulators of sphingosone phosphate receptors
The Scripps Research Institute 2291080*
- Povisone iodine, a novel alternative preservative for ophthalmic compsns
Foresight Biotherapeutics 2291081*
- Carbonate prodrugs and methods of using the same
Neurogesx 2291084*
- Psycho-pharmaceuticals
University College Dublin, National University of Ireland 2291181*
- Salicylate conjugates useful for treating metabolic disorders
Genmedica Therapeutics 2291182*
- Use of dronedarone for preparing a medicament for the treatment of patients with arrhythmia and having an increase of creatinine level due to dronedarone administration
Sanofi-Aventis 2291183*
- Antiviral drugs for treatment of arenavirus infection
Siga Technologies 2291184*
- Octenadine compsn
Aydinoglu, Ahmet Melih 2291185*
- Materials and methods for suppressing and/or treating neurofibroma and related tumours
Indiana University Research and Technology Corp 2291186*
- IDO inhibitors
Newlink Genetics; Lankenau Institute for Medical Research 2291187*
- Compsns and methods to protect cells by blocking entry of pathogen proteins
Virginia Tech Intellectual Properties 2291188*
- Method for treating hyperuricemia employing a SGLT2 inhibitor and compsn containing same
Bristol-Myers Squibb 2291189*
- Vaccine conjugant containing synthetic adjuvant
Infectious Disease Research Institute 2291190*
- Method for preventing and treating neurodegenerative diseases
Mount Sinai School of Medicine of New York University 2291191*
- Anticancer methods using extracts of Anemerrhena asphodeloides bungle
Bionovo 2291192*
- Preparation of intermediates useful in the synthesis of 2’-cyano-2’-deoxy-N4-palmitoyl-1-beta-D-arabinofuransylcytosine
Cyclacel 2291193*
- Compsns and methods for enhanced somatostatin immunogenicity
Braasch Biotech 2291194*
- Vaccine for protection against Lawsonia intracellularis, mycoplasma hyopneumoniae and porcine circo virus
Intervet International 2291195*
- Staphylococcus aureus-specific antibody preparations
Strox Biopharmaceuticals 2291196*
- Use of histamine H4 antagonist for the treatment of post-operative adhesions
Janssen Pharmaceutica 2291197*
- Vesicles comprising an amphiphilic block copolymer for use in epithelial delivery
Biocompatibles 2291198*
- Capsulating system binding to nucleolin
Universidade De Coimbra; Centro De Neurociencias E Biologia Celular De Coimbra 2291199*
- Methods for modulating expression of RBP4
Isis Pharmaceuticals 2291200*